Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-04

Clinical Trial Update: Efficacy and Safety of Garamycin® Sponge in Diabetic Patients With a Moderate or Severe Foot Ulcer Infection [Phase 4]

View source ↗

Summary

Phase 4 trial update on the efficacy and safety of Garamycin Sponge in diabetic foot ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Garamycin Sponge (gentamicin sponge)

Snippet

Sponsor: University Hospital, Geneva | Conditions: Diabetic Foot Ulcer | Phase 4 | Status: COMPLETED | Results posted: 2019-11-04